HopeStage
Back to all studies
RecruitingNCT06538558

Testing Tezampanel for opioid withdrawal during inpatient care

About this title

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Read the official source — NCT06538558
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

Participants stay at the research centre for seven days. They receive tezampanel or placebo (an inactive comparison treatment) daily on days 2 to 7 while the team monitors withdrawal symptoms, safety and drug levels. The study is a dose-escalation trial with several participant cohorts.

Listed locations
IndianapolisSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Participation duration
7-day inpatient stay

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 16, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
40
Sponsor
Proniras Corporation
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06538558
Official title
Show the full official title

A Phase I, Single-Center, Single-Blind, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Pharmacokinetics and Efficacy of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Recruitment & locations

Currently recruiting

Indianapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Proniras Corporation.

Does this study involve medication?

Yes. The study involves medication, including Tezampanel and Placebo.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies